drugset / Trial / NCT02497898
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to study the safety and efficacy of chemotherapy usage followed by CIK transfusion in refractory and/or chemoresistant lymphomas.
Timeline
- Start
- 2015-07
- Primary completion
- 2038-07
- Completion
- 2040-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytokine-induced killer cells (CIK) | Cell therapy | 2e+09 cells | — |